Celebrating Mesothelioma Awareness Day

Celebrating Mesothelioma Awareness Day

Mesothelioma Awareness Day is on September 26th each year. This day has helped to raise awareness about mesothelioma, the asbestos-caused cancer. This day is supported by patients, loved ones, caregivers, researchers, doctors, and survivors. There are many groups working towards a mesothelioma cancer cure. Many of these groups often provide social and financial support to patients. Participating in this day will help to spread information about mesothelioma. This helps raise funds for research on mesothelioma treatments. People can show their support and get involved in many ways. Check to see if there are any Mesothelioma Awareness Day events in your area. The mesothelioma community also comes together on this special day to connect and share their experiences. What Does a Mesothelioma Diagnosis Mean? Mesothelioma is … Continue reading Celebrating Mesothelioma Awareness Day »

Humor Helps Stressed Veteran Mesothelioma Caregivers

Humor Helps Stressed Veteran Mesothelioma Caregivers

Mesothelioma, the asbestos-caused cancer, has a high symptom burden in British military veterans. There is little research on what it is like to live with mesothelioma as a veteran. Or what it is like for veteran mesothelioma caregivers. New research has been published in the journal of Illness, Crisis & Loss on this topic. The article highlights how veterans and their families cope with the stress of the disease. Asbestos Exposure in the British Military Malignant mesothelioma is a disease linked to asbestos exposure. Asbestos exposure in the British Armed Forces has been documented. Many were exposed in damaged buildings during conflict and aid delivery. Mesothelioma is often diagnosed in older people, and survival rates are poor. Symptoms first appear … Continue reading Humor Helps Stressed Veteran Mesothelioma Caregivers »

The RARECARE Project: An International Network Includes Mesothelioma

The RARECARE Project: An International Network Includes Mesothelioma

The RARECARE Project is a network of international clinicians who support rare tumor patients. This includes malignant mesothelioma, the asbestos-caused cancer. RARECARE wants to ensure access to clinical trials. And to the second opinion of cancer specialists. They are working towards guaranteeing equal health care access and better care management. Humble Beginnings In 2008, the European Commission started the RARECARE project. It is a cancer registry with patient data. They are trying to define the incidence, prevalence, and outcome of rare cancers. Soon, the RARECARE registry led to a second project, RARECAREnet. This updated and enlarged the available information on rare cancers in Europe. Mesothelioma remains one of the rarest of rare cancers. It is more common in the UK … Continue reading The RARECARE Project: An International Network Includes Mesothelioma »

New Tool Measures Past Exposure to Asbestos

New Tool Measures Past Exposure to Asbestos

A new Italian study supports the most reliable tool for determining past exposure to asbestos. The study has confirmed what thousands of mesothelioma patients already know. Exposure to asbestos puts them at high risk for malignant mesothelioma. Asbestos is a naturally occurring mineral that has been found throughout the world. It was once called the “magic mineral” because of its seemingly magical properties. Because of its heat-resistant properties, it served as an insulator in factories, schools, homes, and ships. Thousands of workers have come in contact with the material daily, in some cases, for decades. Asbestos is toxic and cancer-causing for human beings. It causes mesothelioma and other asbestos-related diseases. Generally, those who develop asbestos-related diseases show no signs of … Continue reading New Tool Measures Past Exposure to Asbestos »

Major Effect of COVID-19 on Mesothelioma Patient Survival in Italy

Major Effect of COVID-19 on Mesothelioma Patient Survival in Italy

The COVID‐19 pandemic had a major effect on some mesothelioma patients in Italy. A new study in Medical & Clinical Research shows how the pandemic harmed new diagnoses and survival. Malignant mesothelioma is one of the rarest types of cancer. Many people have never even heard of ‘asbestos cancer’ until they are diagnosed. Most do not know anyone else who has it. Social distancing to protect themselves against COVID-19 compounds the problem. The timely diagnosis of mesothelioma is important. Although it may not change the prognosis of the disease, it can help in treatment strategies. Treatment delays due to the COVID-19 pandemic had a major effect on survival rates for some patients. Survival Rate during Pandemic During the COVID-19 pandemic, … Continue reading Major Effect of COVID-19 on Mesothelioma Patient Survival in Italy »

Mesothelioma Multidisciplinary Team Improves Patient Outcomes

Localized Mesothelioma Successfully Treated with Chemotherapy and Surgery

Oxford University Hospital found that a multidisciplinary team is best in mesothelioma care. This treatment approach includes many doctors who are experts in different specialties. Together, they offer the best clinical decision-making team, and they improve patient outcomes. There are many factors that impact clinical decision-making. But this new report focuses on which factors improve mesothelioma patient care. And which factors support informed decisions about follow-up care. Results showed that the most important factor is a strong team of doctors. Two Heads are Better than One Malignant pleural mesothelioma is a rare, incurable cancer coming from asbestos exposure. Patients have a poor prognosis and a median survival rate of 8 to 14 months. Differences in mesothelioma clinical decision-making are common. … Continue reading Mesothelioma Multidisciplinary Team Improves Patient Outcomes »

Earlier Mesothelioma Diagnosis with Machine Learning Model

Earlier Mesothelioma Diagnosis with Machine Learning Model

A new machine learning model can diagnose mesothelioma better than any current model. The model provides new hope for early diagnosis and better treatment of malignant mesothelioma. A machine learning tool is a computer program that gets “smarter” the more it runs. One challenge in predicting mesothelioma is that mesothelioma is very rare. With the exception of mesothelioma specialists, most doctors never even see a single case. The same is true for pathologists. If they do not see mesothelioma patients, they are less likely to see differences that may influence the diagnosis. Doctors trained the new machine learning tool to recognize and diagnose malignant mesothelioma. It works more quickly and accurately. Earlier mesothelioma diagnosis would allow for earlier intervention. This … Continue reading Earlier Mesothelioma Diagnosis with Machine Learning Model »

Mesothelioma and the Promising New Hippo Biomarker

Mesothelioma and the Promising New Hippo Biomarker

A new review in Targeted Oncology looks at a promising new Hippo biomarker in malignant pleural mesothelioma. The new biomarker is rooted in the mesothelioma molecular pathway. A molecular pathway is how molecules work together inside your body. These pathways control cell function. And they are important in developing mesothelioma treatments. Think of molecular pathways as the airport tower controller. These pathways tell mesothelioma treatments where to go and what to do in the body. If doctors can understand how pathways work, they can develop better treatments. The goal is to develop more, and more effective, mesothelioma treatments. Promising Hippo Pathway in Malignant Pleural Mesothelioma While several drugs have been approved for treating mesothelioma, there aren’t a lot. This is … Continue reading Mesothelioma and the Promising New Hippo Biomarker »

Easing the Painful Symptoms of Malignant Pleural Mesothelioma

Easing the Painful Symptoms of Malignant Pleural Mesothelioma

Malignant pleural mesothelioma is an aggressive and rare cancer. There is new hope for reducing the painful symptoms of malignant pleural mesothelioma. A new study in BMC Cancer looked at treatments and the symptom burden of malignant pleural mesothelioma in Europe. The symptoms of malignant pleural mesothelioma are very hard. But there are treatments available to improve quality of life. New data proves that chemotherapy eases mesothelioma symptoms. And it is most likely to improve and maintain health-related quality of life. The Long Journey of Mesothelioma Mesothelioma is the asbestos-caused cancer. Malignant pleural mesothelioma is the most common form of mesothelioma. It accounts for over 90,000 deaths per year globally. It takes a very long time to diagnose mesothelioma. Usually, … Continue reading Easing the Painful Symptoms of Malignant Pleural Mesothelioma »

Serum IgG4: A New Biomarker for Mesothelioma Pleural Effusion

Serum IgG4: A New Biomarker for Mesothelioma Pleural Effusion

Egyptian scientists say a new biomarker is very good at identifying mesothelioma. Pleural effusions are pockets of excess fluid. They collect around the lungs of people with certain kinds of cancer and other conditions. Biomarkers in pleural effusions are proteins and other substances found in mesothelioma patients. The new study suggests that using this biomarker the right way can lead to more accurate diagnoses. The Importance of Biomarkers in Pleural Effusions Pleural mesothelioma is a rare cancer of the lung lining. It is a challenge to diagnose. The early symptoms can be as vague as cough and fatigue. But an accurate diagnosis is often the difference between life and death. As tumors grow, mesothelioma patients produce pleural effusions or ‘water … Continue reading Serum IgG4: A New Biomarker for Mesothelioma Pleural Effusion »

Get your free copy of
“Surviving Mesothelioma” Today!